Cargando…
A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report
Immune checkpoint inhibitor therapy nowadays became a treatment for a wide range of cancers, and may be responsible for various dermatologic adverse effects, including bullous eruptions. In our report, we present a case of late-onset immunotherapy-induced eruption in a 62-year-old woman treated with...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940716/ https://www.ncbi.nlm.nih.gov/pubmed/33747513 http://dx.doi.org/10.1177/2050313X21993279 |
_version_ | 1783661999885910016 |
---|---|
author | Manko, Svitlana Côté, Benoît Provost, Nathalie |
author_facet | Manko, Svitlana Côté, Benoît Provost, Nathalie |
author_sort | Manko, Svitlana |
collection | PubMed |
description | Immune checkpoint inhibitor therapy nowadays became a treatment for a wide range of cancers, and may be responsible for various dermatologic adverse effects, including bullous eruptions. In our report, we present a case of late-onset immunotherapy-induced eruption in a 62-year-old woman treated with anti-programmed cell death-L1 agent durvalumab for metastatic squamous cell carcinoma. Diagnosed as lichenoid dermatitis upon initial presentation, this eruption evolved into necrotic bullous dermatitis after several weeks of phototherapy, with histology and direct immunofluorescence study favoring lichen planus pemphigoides. Thus, this case may be regarded as durvalumab-induced lichenoid dermatitis with phototherapy-triggered progression to necrotic lichen planus pemphigoides-like eruption. The patient’s eruption responded to oral prednisone and immunotherapy interruption. Interestingly, durvalumab reintroduction in this patient led to recurrent lichenoid dermatitis without bullous component. This case of immunotherapy skin toxicity is rather distinctive by its clinical and histopathologic features, with phototherapy as an additional triggering factor. |
format | Online Article Text |
id | pubmed-7940716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-79407162021-03-18 A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report Manko, Svitlana Côté, Benoît Provost, Nathalie SAGE Open Med Case Rep JCMS Case Report Immune checkpoint inhibitor therapy nowadays became a treatment for a wide range of cancers, and may be responsible for various dermatologic adverse effects, including bullous eruptions. In our report, we present a case of late-onset immunotherapy-induced eruption in a 62-year-old woman treated with anti-programmed cell death-L1 agent durvalumab for metastatic squamous cell carcinoma. Diagnosed as lichenoid dermatitis upon initial presentation, this eruption evolved into necrotic bullous dermatitis after several weeks of phototherapy, with histology and direct immunofluorescence study favoring lichen planus pemphigoides. Thus, this case may be regarded as durvalumab-induced lichenoid dermatitis with phototherapy-triggered progression to necrotic lichen planus pemphigoides-like eruption. The patient’s eruption responded to oral prednisone and immunotherapy interruption. Interestingly, durvalumab reintroduction in this patient led to recurrent lichenoid dermatitis without bullous component. This case of immunotherapy skin toxicity is rather distinctive by its clinical and histopathologic features, with phototherapy as an additional triggering factor. SAGE Publications 2021-03-03 /pmc/articles/PMC7940716/ /pubmed/33747513 http://dx.doi.org/10.1177/2050313X21993279 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | JCMS Case Report Manko, Svitlana Côté, Benoît Provost, Nathalie A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title | A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title_full | A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title_fullStr | A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title_full_unstemmed | A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title_short | A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report |
title_sort | case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: a case report |
topic | JCMS Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940716/ https://www.ncbi.nlm.nih.gov/pubmed/33747513 http://dx.doi.org/10.1177/2050313X21993279 |
work_keys_str_mv | AT mankosvitlana acaseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport AT cotebenoit acaseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport AT provostnathalie acaseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport AT mankosvitlana caseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport AT cotebenoit caseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport AT provostnathalie caseofdurvalumabinducedlichenoideruptionevolvingtobullouseruptionafterphototherapyacasereport |